Design Therapeutics, Inc.
DSGNNasdaqCIK 1807120HealthcareFiscal year ends Dec 31
Reports and events: 74 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0308:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-329579 |
| 2026-08-0308:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-329570 |
| 2026-06-1116:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-267485 |
| 2026-05-1807:15 ET | 8-K | 8.01 Other events | 0001193125-26-227875 |
| 2026-04-2816:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-187063 |
| 2026-04-2816:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-187012 |
| 2026-04-2316:06 ET | DEF 14A | Proxy statementPeriod 2026-04-23 | 0001193125-26-173678 |
| 2026-04-0116:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-137861 |
| 2026-03-1121:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-26-000257 |
| 2026-03-0916:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-098491 |
| 2026-03-0916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-098474 |
| 2026-01-3016:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-031772 |
| 2025-11-1817:57 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000710 |
| 2025-11-1217:10 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000657 |
| 2025-11-0516:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266970 |
| 2025-11-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266933 |
| 2025-09-1016:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001807120-25-000004 |
| 2025-08-0716:18 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105062 |
| 2025-08-0716:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-25-105008 |
| 2025-06-1216:18 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-085380 |
| 2025-05-0716:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065643 |
| 2025-05-0716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065613 |
| 2025-04-2416:05 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0000950170-25-058008 |
| 2025-03-1007:16 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-035910 |
| 2025-03-1007:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-035909 |
| 2025-01-1309:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004612 |
| 2024-11-0716:13 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123349 |
| 2024-11-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123289 |
| 2024-08-1318:53 ET | SC 13D/A | Ownership report, active investor, amended | 0000935836-24-000514 |
| 2024-08-0508:12 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090337 |
| 2024-08-0508:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-090332 |
| 2024-06-1716:12 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-074243 |
| 2024-05-0816:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055788 |
| 2024-05-0816:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055645 |
| 2024-04-2516:30 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0000950170-24-048385 |
| 2024-03-1916:17 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-033492 |
| 2024-03-1916:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-033475 |
| 2023-11-1316:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062958 |
| 2023-11-1316:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062937 |
| 2023-08-2517:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-221586 |
| 2023-08-1416:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-042411 |
| 2023-08-1416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-042392 |
| 2023-06-0116:45 ET | 8-K | 5.07 Shareholder vote results | 0001193125-23-159009 |
| 2023-05-0916:20 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019714 |
| 2023-05-0916:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-019682 |
| 2023-04-1316:36 ET | DEF 14A | Proxy statementPeriod 2023-05-31 | 0000950170-23-012723 |
| 2023-03-1416:13 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-007869 |
| 2023-03-1416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-007864 |
| 2022-12-2216:25 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-22-311061 |
| 2022-11-0316:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021885 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.